Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 11, 2008 - Issue 3
27
Views
3
CrossRef citations to date
0
Altmetric
Research articles

Brain endocannabinoid system is involved in fluoxetine-induced anorexia

, , , , &
Pages 111-118 | Published online: 19 Jul 2013

References

  • Di Marzo V, Bifulco M, De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 2004; 3: 771–784.
  • Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance. Nat Neurosci 2005; 8: 585–589.
  • Jamshidi N, Taylor DA. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 2001; 134: 1151–1154.
  • Kirkham TC, Williams CM, Fezza F, Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 2002; 136: 550–557.
  • Kirkham TC. Opioids and feeding reward. Appetite 1991; 17: 74–75.
  • Williams CM, Kirkham TC. Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 2002; 71: 333–340.
  • Chua Jr SC, Chung WK, Wu-Peng XS, et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996; 271: 994–996.
  • Di Marzo V, Goparaju SK, Wang L, et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001; 410: 822–825.
  • Greenberg D, Weatherford SC. Obese and lean Zucker rats differ in preferences for sham-fed corn oil or sucrose. Am J Physiol 1990; 259: R1093 -R1095.
  • Wong DT, Bymaster FP, Englemam EA. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 1995; 57: 411 —441.
  • Mackay FJ, Dunn NR, Wilton LV, Pierce GL, Freemantle SN, Mann RD. A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiol Drug Safe 1997; 6: 235–246.
  • Anelli M, Bizzi A, Caccia S, Codegoni AM, Fracasso C, Garattini S. Anorectic activity of fluoxetine and norfluoxetine in mice, rats and guinea-pigs. J Pharm Pharmacol 1992; 44: 696–698.
  • Halford JC, Harrold JA, Boyland EJ, Lawton CL, Blundell JE. Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs 2007; 67: 27–55.
  • Hao S, Avraham Y, Mechoulam R, Berry EM. Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol 2000; 392: 147–156.
  • Moranta D, Esteban S, Garcia-Sevilla JA. Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 516–524.
  • Tzavara ET, Davis RJ, Perry KW, et al. The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br J Pharmacol 2003;138: 544–553.
  • Prendergast MA, Yells DP, Balogh SE, Paige SR, Hendricks SE. Fluoxetine differentially suppresses sucrose solution consumption in free-fed and food-deprived rats - reversal by amantadine. Med Sci Monit 2002; 8: BR385 -BR390.
  • Hagan MM, Holguin FD, Cabello CE, Hanscom DR, Moss DE. Combined naloxone and fluoxetine on deprivation-induced binge eating of palatable foods in rats. Pharmacol Biochem Behav 1997; 58: 1103–1107.
  • Churruca I, Casis L, Portillo MP, et al. Fluoxetine alters mu opioid receptor expression in obese Zucker rat hypothalamus. Neurosci Res Commun 2004; 35: 1–7.
  • Kirkham TC, Williams CM. Synergistic effects of opioid and cannabinoid antagonists on food intake. Psychopharmacology (Berl) 2001; 153: 267–270.
  • Harrold JA, Elliott JC, King PJ, Widdowson PS, Williams G. Down- regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? Brain Res 2002; 952: 232–238.
  • Simiand J, Keane M, Keane PE, Soubrie P. SR141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 1998; 9: 179–181.
  • Rowland NE, Mukherjee M, Robertson K. Effects of the cannabinoid receptor antagonist SR141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology (Berl) 2001; 159: 111–116.
  • Gallate JE, McGregor IS. The motivation for beer in rats: effects of ritanserin, naloxone and SR141716. Psychopharmacology (Berl) 1999; 142: 302–308.
  • Trojniar W, Wise RA. Facilitory effect of delta 9-tetrahydrocannabinol on hypothalamically induced feeding. Psychopharmacology (Berl) 1991; 103: 172–176.
  • Jarosz PA, Metzger BL. The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating. Biol Res Nurs 2002; 3: 198–209.
  • Marx J. Drug development. Drugs inspired by a drug. Science 2006; 311: 322–325.
  • Vickers SP, Webster LJ, Wyatt A, Dourish CT, Kennett GA. Preferential effects of the cannabinoid CB1 receptor antagonist, SR141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology (Berl) 2003; 167: 103–111.
  • Dryden S, Brown M, King P, Williams G. Decreased plasma leptin levels in lean and obese Zucker rats after treatment with the serotonin reuptake inhibitor fluoxetine. Horm Metab Res 1999; 31: 363–366.
  • Gutiérrez A, Saraclfaar G, Casis L, et al. Effects of fluoxetine administration on neuropeptide Y and orexins in obese Zucker rat hypothalamus. Obes Res 2002; 10: 532–540.
  • Churruca I, Portillo MP, Gutiérrez A, et al. Effects of fluoxetine administration on regional galanin expression in obese Zucker rat hypothalamus. Nutr Neurosci 2004; 7: 171–175.
  • Goldstein DJ, Hamilton SH, Masica DN, Beasley CM. Fluoxetine in medically stable, depressed geriatric patients: effect on weight. J Clin Psychopharmacol 1997; 17: 365–369.
  • Oliva JM, Uriguen L, Perez-Rial S, Manzanares J. Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain. Neuropharmacology 2005; 49: 618–626.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.